Biotech

All Articles

A better examine Brutal Biotech's Strong 15

.Within this week's episode of "The Leading Line," we are actually diving right into Strong Biotech'...

Lilly faces period 2 breakdown of tau-targeting med

.The confetti is still soaring coming from Eli Lilly's event celebrating the approval of Alzheimer's...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of significant management hirings, firings as we...

Lykos will certainly ask FDA to rethink its decision following rejection of MDMA therapy for trauma

.Following an unsatisfactory presenting for Lykos Rehabs' MDMA candidate for post-traumatic stress d...

AN 2 halves roll call, ceases stage 3 trial after information disappoint

.AN2 Therapies is re-thinking its business in feedback to poor midphase data, vowing to give up half...

Merck pays out $700M for bispecific, spying autoimmune position as well as possibility to challenge Amgen in cancer cells

.Merck &amp Co. is paying out $700 thousand beforehand to test Amgen in a blood stream cancer market...

Gilead spends J&ampJ $320M to go out licensing package for seladelpar

.Along With Gilead Sciences on the verge of an FDA decision for its liver ailment drug seladelpar, t...

' All hands on deck' at Lilly as peers target excessive weight market

.CEO David Ricks can see the companies establishing camping tents at basecamp behind Eli Lilly in an...

Entero giving up personnel, moving out of office and also stopping briefly R&ampD

.Mattress Liquidators has actually switched Entero Therapeutics white colored as a sheet. The collec...

Exelixis drops ADC after choosing it is actually no suit for Tivdak

.Exelixis is quiting on its tissue element (TF)- targeting antibody-drug conjugate after ending the ...